Cargando…
Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice
Trivanga Bhasma, a metallic preparation containing Bhasmas of Naga (lead), Vanga (tin) and Yashada (zinc), was studied for repeated dose toxicity in Swiss albino mice to estimate No Observed Effect Level (NOEL) or No Observed Adverse Effect Level (NOAEL). A total of 80 Swiss albino mice of either se...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764869/ https://www.ncbi.nlm.nih.gov/pubmed/24049417 http://dx.doi.org/10.4103/0974-8520.115449 |
_version_ | 1782283195393245184 |
---|---|
author | Jamadagni, Pallavi S. Jamadagni, Shrirang B. Singh, Rajendrakumar Gaidhani, Sudesh N. Upadhyay, Sachchidanand Hazra, Jayram |
author_facet | Jamadagni, Pallavi S. Jamadagni, Shrirang B. Singh, Rajendrakumar Gaidhani, Sudesh N. Upadhyay, Sachchidanand Hazra, Jayram |
author_sort | Jamadagni, Pallavi S. |
collection | PubMed |
description | Trivanga Bhasma, a metallic preparation containing Bhasmas of Naga (lead), Vanga (tin) and Yashada (zinc), was studied for repeated dose toxicity in Swiss albino mice to estimate No Observed Effect Level (NOEL) or No Observed Adverse Effect Level (NOAEL). A total of 80 Swiss albino mice of either sex with an average body weight of 28-30 g were equally divided into four groups (Group I, II, III, and IV). Group I served as control and was given vehicle (honey: water in 2:3 ratio) Group II, III, and IV received Trivanga Bhasma @ 7.8, 39.5,and 78 mg/kg body weight for 90 consecutive days. The effect of drug was assessed on body weight, feed and water consumption changes, hematological, and histopathological parameters. At the end of the study, all animals were sacrificed and examined for gross pathological changes. Histopathological evaluation was performed for control and high dose group. Trivanga Bhasma was found to be safe. No significant clinical signs were noted in all groups studied. No major alterations were observed during histopathological evaluation. Hence, dose rate of 78 mg/kg body weight was established as NOAEL. It is suggested to carry out a toxicity study at possible higher doses and in a different species so as to establish target organ of toxicity. |
format | Online Article Text |
id | pubmed-3764869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-37648692013-09-18 Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice Jamadagni, Pallavi S. Jamadagni, Shrirang B. Singh, Rajendrakumar Gaidhani, Sudesh N. Upadhyay, Sachchidanand Hazra, Jayram Ayu Pharmacological Study Trivanga Bhasma, a metallic preparation containing Bhasmas of Naga (lead), Vanga (tin) and Yashada (zinc), was studied for repeated dose toxicity in Swiss albino mice to estimate No Observed Effect Level (NOEL) or No Observed Adverse Effect Level (NOAEL). A total of 80 Swiss albino mice of either sex with an average body weight of 28-30 g were equally divided into four groups (Group I, II, III, and IV). Group I served as control and was given vehicle (honey: water in 2:3 ratio) Group II, III, and IV received Trivanga Bhasma @ 7.8, 39.5,and 78 mg/kg body weight for 90 consecutive days. The effect of drug was assessed on body weight, feed and water consumption changes, hematological, and histopathological parameters. At the end of the study, all animals were sacrificed and examined for gross pathological changes. Histopathological evaluation was performed for control and high dose group. Trivanga Bhasma was found to be safe. No significant clinical signs were noted in all groups studied. No major alterations were observed during histopathological evaluation. Hence, dose rate of 78 mg/kg body weight was established as NOAEL. It is suggested to carry out a toxicity study at possible higher doses and in a different species so as to establish target organ of toxicity. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3764869/ /pubmed/24049417 http://dx.doi.org/10.4103/0974-8520.115449 Text en Copyright: © AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pharmacological Study Jamadagni, Pallavi S. Jamadagni, Shrirang B. Singh, Rajendrakumar Gaidhani, Sudesh N. Upadhyay, Sachchidanand Hazra, Jayram Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice |
title | Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice |
title_full | Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice |
title_fullStr | Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice |
title_full_unstemmed | Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice |
title_short | Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice |
title_sort | repeated dose oral toxicity of trivanga bhasma in swiss albino mice |
topic | Pharmacological Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764869/ https://www.ncbi.nlm.nih.gov/pubmed/24049417 http://dx.doi.org/10.4103/0974-8520.115449 |
work_keys_str_mv | AT jamadagnipallavis repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice AT jamadagnishrirangb repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice AT singhrajendrakumar repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice AT gaidhanisudeshn repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice AT upadhyaysachchidanand repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice AT hazrajayram repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice |